Literature DB >> 20449629

Effects of irradiation on tumor cell survival, invasion and angiogenesis.

Odysseas Kargiotis1, Aliki Geka, Jasti S Rao, Athanasios P Kyritsis.   

Abstract

Ionizing irradiation is a widely applied therapeutic method for the majority of solid malignant neoplasms, including brain tumors where, depending on localization, this might often be the only feasible primary intervention.Without doubt, it has been proved to be a fundamental tool available in the battlefield against cancer, offering a clear survival benefit in most cases. However, numerous studies have associated tumor irradiation with enhanced aggressive phenotype of the remaining cancer cells. A cell population manages to survive after the exposure, either because it receives sublethal doses and/or because it successfully utilizes the repair mechanisms. The biology of irradiated cells is altered leading to up-regulation of genes that favor cell survival, invasion and angiogenesis. In addition, hypoxia within the tumor mass limits the cytotoxicity of irradiation, whereas irradiation itself may worsen hypoxic conditions, which also contribute to the generation of resistant cells. Activation of cell surface receptors, such as the epidermal growth factor receptor, utilization of signaling pathways, and over-expression of cytokines, proteases and growth factors, for example the matrix metalloproteinases and vascular endothelial growth factor, protect tumor and non-tumor cells from apoptosis, increase their ability to invade to adjacent or distant areas, and trigger angiogenesis. This review will try to unfold the various molecular events and interactions that control tumor cell survival, invasion and angiogenesis and which are elicited or influenced by irradiation of the tumor mass, and to emphasize the importance of combining irradiation therapy with molecular targeting.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20449629     DOI: 10.1007/s11060-010-0199-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  141 in total

1.  Induction of sister chromatid exchanges by extremely low doses of alpha-particles.

Authors:  H Nagasawa; J B Little
Journal:  Cancer Res       Date:  1992-11-15       Impact factor: 12.701

2.  Response of endothelial cells to a dual tyrosine kinase receptor inhibition combined with irradiation.

Authors:  Alexandre Bozec; Patricia Formento; Joseph Ciccolini; Raphaëlle Fanciullino; Laetitia Padovani; Xavier Murraciole; Jean-Louis Fischel; Gerard Milano
Journal:  Mol Cancer Ther       Date:  2005-12       Impact factor: 6.261

Review 3.  Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival.

Authors:  Steven Grant; Liang Qiao; Paul Dent
Journal:  Front Biosci       Date:  2002-02-01

4.  Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB.

Authors:  Sylvie Monferran; Nicolas Skuli; Caroline Delmas; Gilles Favre; Jacques Bonnet; Elizabeth Cohen-Jonathan-Moyal; Christine Toulas
Journal:  Int J Cancer       Date:  2008-07-15       Impact factor: 7.396

Review 5.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

6.  Pro-invasive gene regulating effect of irradiation and combined temozolomide-radiation treatment on surviving human malignant glioma cells.

Authors:  Daniela Trog; Kristina Yeghiazaryan; Michael Fountoulakis; Arno Friedlein; Heike Moenkemann; Nicolai Haertel; Heinrich Schueller; Winrich Breipohl; Hans Schild; David Leppert; Olga Golubnitschaja
Journal:  Eur J Pharmacol       Date:  2006-05-24       Impact factor: 4.432

7.  Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death.

Authors:  P Dent; D B Reardon; J S Park; G Bowers; C Logsdon; K Valerie; R Schmidt-Ullrich
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

8.  Inhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cells.

Authors:  Vladimir N Ivanov; Hongning Zhou; Michael A Partridge; Tom K Hei
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

9.  Radiosurgery as part of the initial management of patients with malignant gliomas.

Authors:  J S Loeffler; E Alexander; W M Shea; P Y Wen; H A Fine; H M Kooy; P M Black
Journal:  J Clin Oncol       Date:  1992-09       Impact factor: 44.544

10.  In vitro irradiation of basement membrane enhances the invasiveness of breast cancer cells.

Authors:  B Paquette; C Baptiste; H Therriault; G Arguin; B Plouffe; R Lemay
Journal:  Br J Cancer       Date:  2007-11-06       Impact factor: 7.640

View more
  29 in total

Review 1.  Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.

Authors:  John M L Ebos; Robert S Kerbel
Journal:  Nat Rev Clin Oncol       Date:  2011-03-01       Impact factor: 66.675

2.  NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth Delay.

Authors:  Lisa A Ridnour; Robert Y S Cheng; Jonathan M Weiss; Sukhbir Kaur; David R Soto-Pantoja; Debashree Basudhar; Julie L Heinecke; C Andrew Stewart; William DeGraff; Anastasia L Sowers; Angela Thetford; Aparna H Kesarwala; David D Roberts; Howard A Young; James B Mitchell; Giorgio Trinchieri; Robert H Wiltrout; David A Wink
Journal:  Cancer Res       Date:  2015-05-19       Impact factor: 12.701

3.  The radiomimetic enediyne, 20'-deschloro-C-1027 induces inter-strand DNA crosslinks in hypoxic cells and overcomes cytotoxic radioresistance.

Authors:  Terry A Beerman; Loretta S Gawron; Ben Shen; Daniel R Kennedy
Journal:  DNA Repair (Amst)       Date:  2014-06-28

Review 4.  The Future of Combining Carbon-Ion Radiotherapy with Immunotherapy: Evidence and Progress in Mouse Models.

Authors:  Takashi Shimokawa; Liqiu Ma; Ken Ando; Katsutoshi Sato; Takashi Imai
Journal:  Int J Part Ther       Date:  2016-08-29

5.  Can anticancer chemotherapy promote the progression of brain metastases?

Authors:  Aymeric Amelot; Louis-Marie Terrier; Bertrand Mathon; Ann-Rose Cook; Jean-Jacques Mazeron; Charles-Ambroise Valery; Philippe Cornu; Marc Leveque; Alexandre Carpentier
Journal:  Med Oncol       Date:  2018-02-09       Impact factor: 3.064

6.  Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.

Authors:  Timothy P Kegelman; Bainan Wu; Swadesh K Das; Sarmistha Talukdar; Jason M Beckta; Bin Hu; Luni Emdad; Kristoffer Valerie; Devanand Sarkar; Frank B Furnari; Webster K Cavenee; Jun Wei; Angela Purves; Surya K De; Maurizio Pellecchia; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-23       Impact factor: 11.205

Review 7.  Xanthones from mangosteen extracts as natural chemopreventive agents: potential anticancer drugs.

Authors:  T Shan; Q Ma; K Guo; J Liu; W Li; F Wang; E Wu
Journal:  Curr Mol Med       Date:  2011-11       Impact factor: 2.222

8.  Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma.

Authors:  D Kesanakurti; C Chetty; D Rajasekhar Maddirela; M Gujrati; J S Rao
Journal:  Oncogene       Date:  2012-11-26       Impact factor: 9.867

9.  Irradiation affects cellular properties and Eph receptor expression in human melanoma cells.

Authors:  Birgit Mosch; Doreen Pietzsch; Jens Pietzsch
Journal:  Cell Adh Migr       Date:  2012-03-01       Impact factor: 3.405

10.  MMP-2 suppression abrogates irradiation-induced microtubule formation in endothelial cells by inhibiting αvβ3-mediated SDF-1/CXCR4 signaling.

Authors:  Dilip Rajasekhar Maddirela; Divya Kesanakurti; Meena Gujrati; Jasti S Rao
Journal:  Int J Oncol       Date:  2013-02-04       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.